Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

New video on the Market Access Insider Youtube channel: Interview with Luigi Mazzei about market access for medical devices in Italy

MTRC has released the new video on the Market Access Insider Youtube channel. Oleg Borisenko spoke to Mr. Luigi Mazzei, Country Director at Edwards Lifesciences about market access for medical devices in Italy.

The interview covered organization and financing of the health care system in Italy, regional aspects of market access, the role of health technology assessment in market access for medical devices, role in the industry in market access processes. 

The interview was recorded in April 2019.

Watch the interview here.

Tags
Services of MTRC
Italy
MTRC Youtube channel

The latest related news

09
May 2024

Rapid HTAs of three medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 8521 of April 19, 2024, Tuscany Regional Healthcare published three reassessments of medical devices in the cardiovascular, peripheral vascular, and e-health areas.
Read more
11
Apr 2024

Rapid HTAs of four medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 6700 of March 27, 2024, Tuscany Regional Healthcare published three new assessments and one re-assessment of medical devices in the cardiovascular, men’s health, nephrology and urology, and surgical procedures areas.
Read more
08
Apr 2024

MTRC launched Knowledge Zone with brief overviews of the market access landscape and challenges for individual types of medical technologies in Europe

Market access is a rapidly changing field and the landscape varies for different types of medical technologies. To provide an additional, easy-to-access source of high-level information about key themes in the market access landscape and challenges for individual types of medical technologies, MTRC launched a dedicated Knowledge Zone on the website. Currently, the Knowledge Zone includes information about procedure coding, payment mechanisms, policy considerations, HTA, and future challenges for market access for 12 types of medical technologies. In the coming weeks, the Zone will expand 40 key technology groups
Read more
02
Apr 2024

National tariffs for outpatient specialist and prosthetic care postponed until 2025 in Italy

The Essential Levels of Care (LEA) defines outpatient specialist and prosthetic care guaranteed to the Italian population. Although the LEA document was brought in 2017, the national tariffs for outpatient specialist and prosthetic care were launched in April last year after seven years of development. They were supposed to come into effect on January 1, 2024 (later postponed to April 1, 2024). However, on March 27, 2024, the need for tariff revision and the new Decree postponing the tariffs until January 2025 was announced by the Italian Ministry of Health
Read more